Navigation Links
Severe Low Blood Sugar Ups Older Diabetics' Dementia Risk
Date:4/14/2009

Study finds being hospitalized for hypoglycemia linked to mental decline

TUESDAY, April 14 (HealthDay News) -- Older individuals with type 2 diabetes who have been hospitalized with severe low blood sugar levels seem to have a greater risk of developing dementia, new research suggests.

It's not yet clear whether less severe episodes of low blood sugar, which are more common, are also linked with an increased dementia risk, according to a study in the April 15 issue of the Journal of the American Medical Association, a themed issue on diabetes.

"Hypoglycemic episodes that were severe enough to require hospitalization or an emergency-room visit were associated with a greater risk of dementia, particularly for patients who had multiple episodes. And these findings, a little bit to our surprise, were independent of glycemic control," study author Rachel A. Whitmer, of Kaiser Permanente in Oakland, Calif., said during a Tuesday teleconference. "Episodes of hypoglycemia may be associated with neurological consequences in patients already at risk for dementia. This study seems to suggest that hypoglycemia is one of the reasons people with type 2 diabetes are at a higher risk for dementia. It also adds to the evidence base that balance of glycemic control is a critical issue, and particularly for the elderly."

People with type 2 diabetes are at a 32 percent greater risk for dementia, although the reasons for that are not clear. People with pre-diabetes are also at greater risk, Whitmer noted.

However, the study looks at association only, and doesn't actually prove any cause-and-effect link between the two conditions, cautioned Dr. Nir Barzilai, director of the Institute for Aging Research at Albert Einstein College of Medicine and the Montefiore Hospital Diabetes Clinic in New York City.

"It could be fluctuation of glucose. We know that hyperglycemia [high blood sugar] is also very toxic to the cells. All those things cannot be dissected on a study like this," he said.

Whitmer also noted that hypoglycemia is likely only one reason for the heightened risk of dementia in individuals with type 2 diabetes.

While previous studies have linked cognitive impairment in children and adults with type 1 diabetes, it's not clear whether the same link applies to older individuals with type 2 diabetes or what mechanism might be underlying such a connection.

The issue is an important one, with an ever-growing population of people suffering from type 2 diabetes. In the United States alone, some 24 million people have the condition, with lots more to come as the population ages.

Hypoglycemic episodes are marked by dizziness, fainting and even seizures.

The authors followed 16,667 patients with type 2 diabetes, average age 65, from 1980 to 2007. Twenty-two years of the follow-up were devoted to chronicling hypoglycemic episodes, and more than four years were spent to following dementia diagnoses.

The association that was found could be attributable to any of a number of possible mechanisms, including accelerated death of nerve cells in the brain or less blood supply to the brain, the authors stated. Such a link could also be a result of too much insulin over time, again possibly contributing to neuronal damage or other brain changes.

But the whole picture is likely to be much more complicated, Barzilai said.

"The glucose concentrations in the brain are much, much lower than in the [rest of the body], and it takes it a long time to actually adjust if you change the peripheral glucose for the brain to have lower glucose," he explained. "Not only that, but the neurons in the brain are really not fed by glucose but by other metabolites. The rest of the body, when glucose goes down, will feel it. The brain is totally different story."

Although balanced blood-sugar control is a good strategy in theory, it's difficult to attain and difficult to monitor.

"The trouble is, when you try to keep blood sugar in the normal range, there's a higher risk of hypoglycemia," said Michael Horseman, an associate professor of pharmacy practice at the Texas A&M Health Science Center Irma Lerma Rangel College of Pharmacy. "There hasn't been a study that I'm aware of where they made a serious attempt to keep blood sugar in the normal range that didn't have episodes of hypoglycemia."

Barzilai agreed: "You give them a little bit of insulin, and they get hypoglycemia. You give them a little less, the glucose goes very high. It's individual. It's not that you know what to do with every patient."

"It does underline the fact, if we had drugs that don't produce hypoglycemia, we certainly would be better off," he added.

More information

Visit the American Diabetes Association for more on type 2 diabetes.



SOURCES: Nir Barzilai, M.D., director, Institute for Aging Research, Albert Einstein College of Medicine and the Montefiore Hospital Diabetes Clinic, New York City; Michael Horseman, Pharm.D., associate professor, pharmacy practice, Texas A&M Health Science Center, Irma Lerma Rangel College of Pharmacy, College Station; April 14, 2009, teleconference with: Rachel A. Whitmer, Ph.D., Kaiser Permanente, Oakland, Calif.; April 15, 2009, Journal of the American Medical Association


'/>"/>
Copyright©2009 ScoutNews,LLC.
All rights reserved  

Related medicine news :

1. New Topical Painkiller Relieves Severe Pain in Minutes
2. ACell, Inc. Founder Mentioned on the Oprah Winfrey Show as Inventor of Powder for Healing Severed Fingers
3. A severe vomiting sickness with chronic cannabis abuse
4. Innovative Shoulder Surgery Offers Exciting New Option for South Florida Residents with Severe Shoulder Problems
5. New Treatments Improve Control for Severe Asthma
6. Experimental Drug May Dampen Severe Asthma
7. Varicella zoster infection causes severe autoimmune hepatitis
8. Many Combat Vets Suffer Severe Headaches Upon Return
9. Newly Published Menopause Study: Bioidentical and FDA-Approved Divigel(R) (estradiol gel) 0.1 Percent Safe and Effective Treatment for Moderate to Severe Hot Flashes Associated With Menopause
10. Casting Seems Best for Severe Ankle Sprains
11. ROXRO Announces FDA Accepts for Review NDA for ROX-888 for the Management of Acute Moderate to Severe Pain
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Severe Low Blood Sugar Ups Older Diabetics' Dementia Risk
(Date:12/7/2016)... ... December 07, 2016 , ... Gensuite ... Brilliance Awards under the Best New Product Launch category. Gensuite’s entry on their ... experience. , BOC Global Events & Training Group is a professional event and ...
(Date:12/7/2016)... ... December 07, 2016 , ... “The Road To Restoration”: an ... not a one hour a week showing of hands. “The Road To Restoration” is ... “Perhaps you are familiar with the brass ring that you could reach out for, ...
(Date:12/7/2016)... , ... December 07, 2016 , ... “Fred Rides a ... Christmas Day that follows. , “Fred Rides a Train” is the creation of ... short stories since her teen years in Michigan. The "Fred, the Dog" series is ...
(Date:12/7/2016)... ... 2016 , ... Dr. Greg Leyer, the Chief Scientific Officer ... DC workshop on November 2nd. The conference was an opportunity for both probiotic ... regulations. , Dr. Leyer spoke about two main topics at the IPA ...
(Date:12/6/2016)... ... 06, 2016 , ... People with Parkinson’s disease and cognitive ... type of MRI, according to a study appearing online in the journal Radiology. ... characterized by tremors or trembling and stiffness in the limbs, impaired balance and ...
Breaking Medicine News(10 mins):
(Date:12/6/2016)... Dec. 6, 2016 Eurofins Genomics today ... the College of American Pathologists (CAP) and certification ... its new laboratory in Louisville, KY ... North American headquarters. "Our new CLIA-licensed ... which is still considered the ,Gold Standard, method ...
(Date:12/6/2016)... WESTLAKE VILLAGE, Calif. , Dec. 6, ... a privately held, clinical-stage medical dermatology and ... Creabilis plc, a privately held specialty pharmaceutical ... for common inflammatory skin conditions, including psoriasis, ... terms of the agreement, Sienna will make ...
(Date:12/6/2016)... 2016  Regulus Therapeutics Inc. (NASDAQ: ... and development of innovative medicines targeting microRNAs, today ... R&D day, held in New York ... anti-miR targeting microRNA-27 (miR-27) for the treatment of ... anti-miR targeting microRNA-17 (miR-17) for the treatment of ...
Breaking Medicine Technology: